Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 11:47 AM
Ignite Modification Date: 2025-12-26 @ 11:47 AM
NCT ID: NCT05481216
Description: Adverse events were not assessed were for this study, only deaths and serious adverse events were recorded(hospitalisations).
Frequency Threshold: 0
Time Frame: Baseline to week 6
Study: NCT05481216
Study Brief: HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
PLWHIV With COVID-19 Cases Patients who are at least 18 years of age with documented HIV-1 infection and confirmed SARS-CoV-2 infection by documented, or patient-reported, positive result on PCR testing of a nasopharyngeal or respiratory sample, before 1st April 2021. COVID-19: Diagnosed with COVID-19 infection HIV-1 infection: Diagnosed with HIV-1 infection 24 None 224 486 0 0 View
HIV Seronegative Patients With COVID-19 Controls Patients at least 18 years of age with confirmed SARS-CoV-2 infection by documented, or patient-reported, positive result on PCR testing of a nasopharyngeal or respiratory sample, before 1st April 2021. COVID-19: Diagnosed with COVID-19 infection 23 None 231 1106 0 0 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Mortality SYSTEMATIC_ASSESSMENT General disorders None View
Hospitalisation SYSTEMATIC_ASSESSMENT General disorders None View
Other Events(If Any):